Asep Medical Holdings Inc (SEPSF)

USD 0.39

(0.0%)

Total Debt Summary of Asep Medical Holdings Inc

  • Asep Medical Holdings Inc's latest annual total debt in 2023 was 20 Thousand CAD , down 0.0% from previous year.
  • Asep Medical Holdings Inc's latest quarterly total debt in 2024 Q2 was 20 Thousand CAD , up 7.55% from previous quarter.
  • Asep Medical Holdings Inc reported annual total debt of - CAD in 2022, down 0.0% from previous year.
  • Asep Medical Holdings Inc reported annual total debt of - CAD in 2021, down -100.0% from previous year.
  • Asep Medical Holdings Inc reported quarterly total debt of 20 Thousand CAD for 2024 Q2, up 7.55% from previous quarter.
  • Asep Medical Holdings Inc reported quarterly total debt of - CAD for 2023 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of Asep Medical Holdings Inc (2023 - 2019)

Historical Annual Total Debt of Asep Medical Holdings Inc (2023 - 2019)

Year Total Debt Total Debt Growth
2023 20 Thousand CAD 0.0%
2022 - CAD 0.0%
2021 - CAD -100.0%
2020 140.71 Thousand CAD 27.16%
2019 110.65 Thousand CAD 0.0%

Peer Total Debt Comparison of Asep Medical Holdings Inc

Name Total Debt Total Debt Difference
Bioxytran, Inc. 1.92 Million USD 98.961%
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.951%
Institute of Biomedical Research Corp. 401.84 Thousand USD 95.023%
SQZ Biotechnologies Company 27.47 Million USD 99.927%
Intellipharmaceutics International Inc. 2.32 Million USD 99.14%
Evofem Biosciences, Inc. 43.37 Million USD 99.954%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.933%
Propanc Biopharma, Inc. 948.27 Thousand USD 97.891%
Marizyme, Inc. 18.71 Million USD 99.893%
Genus plc 233.1 Million USD 99.991%
Pharming Group N.V. 171.54 Million USD 99.988%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 97.748%
CNBX Pharmaceuticals Inc. 1.34 Million USD 98.511%
Nymox Pharmaceutical Corporation 750 Thousand USD 97.333%
ContraFect Corporation 2.88 Million USD 99.306%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 98.617%
IMV Inc. 28.88 Million USD 99.931%
AXIM Biotechnologies, Inc. 5.65 Million USD 99.647%
ONE Bio Corp. 19.71 Million USD 99.899%
RVL Pharmaceuticals plc 57.48 Million USD 99.965%
Mesoblast Limited 118.7 Million USD 99.983%
MultiCell Technologies, Inc. 202.58 USD -9772.643%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.94%
Genscript Biotech Corporation 417.73 Million USD 99.995%
Neon Bloom, Inc. 630.07 Thousand USD 96.826%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 98.372%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 99.515%
Biomind Labs Inc. 735.54 Thousand USD 97.281%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 99.339%
Oncotelic Therapeutics, Inc. 12.99 Million USD 99.846%
Skye Bioscience, Inc. 4.61 Million USD 99.567%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 94.44%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 99.317%
THC Farmaceuticals, Inc. 141.51 Thousand USD 85.868%
PsyBio Therapeutics Corp. 135.48 Thousand USD 85.238%
Arch Therapeutics, Inc. 5.87 Million USD 99.659%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 25.71 Thousand USD 22.236%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 1.49 Million USD 98.662%
Q BioMed Inc. 4.1 Million USD 99.513%
GB Sciences, Inc. 1.75 Million USD 98.863%
Alpha Cognition Inc. 1.22 Million USD 98.361%
CSL Limited 12.18 Billion USD 100.0%
Agentix Corp. 50 Thousand USD 60.0%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.97%
Enzolytics Inc. 996.33 Thousand USD 97.993%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. 6.49 Million USD 99.692%
Nuo Therapeutics, Inc. 255.59 Thousand USD 92.175%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. 2.25 Million USD 99.114%
argenx SE 20 Million USD 99.9%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.956%
HST Global, Inc. 98.31 Thousand USD 79.658%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD 91.959%
Halberd Corporation 150 Thousand USD 86.667%
Endonovo Therapeutics, Inc. 7.07 Million USD 99.717%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -95.599%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 99.262%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 99.166%
AVAX Technologies, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 91.277%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD 86.546%
Ember Therapeutics, Inc. 200.61 Thousand USD 90.031%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. 2.19 Million USD 99.091%
Helix BioMedix, Inc. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 99.902%
Kadimastem Ltd 891.22 Thousand USD 97.756%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 4.71 Million USD 99.575%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 250.18 Thousand USD 92.006%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation 33.6 Thousand USD 40.487%
Cell Source, Inc. 9.25 Million USD 99.784%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 97.355%
Regen BioPharma, Inc. 756.2 Thousand USD 97.355%
Affymax, Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 95.87%
Itoco Inc. 228.37 Thousand USD 91.243%
Rasna Therapeutics, Inc. 210.97 Thousand USD 90.52%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 99.599%
International Stem Cell Corporation 4.17 Million USD 99.521%
CytoDyn Inc. 30.07 Million USD 99.934%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 94.316%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.744%
SYBLEU INC 477.5 Thousand USD 95.812%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD 83.673%
Rebus Holdings, Inc. 310 Thousand USD 93.548%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 99.578%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD 67.955%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 99.083%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 99.759%
Adhera Therapeutics, Inc. 8.58 Million USD 99.767%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 98.714%
Innovation Pharmaceuticals Inc. 268 Thousand USD 92.537%
Neutra Corp. 54.15 Thousand USD 63.07%
Windtree Therapeutics, Inc. 1.83 Million USD 98.907%
PureTech Health plc 25.51 Million USD 99.922%
Coeptis Therapeutics, Inc. 1.22 Million USD 98.366%
IXICO plc 472.02 Thousand USD 95.763%
IntelGenx Technologies Corp. 15.5 Million USD 99.871%
Gelesis Holdings, Inc. 62.26 Million USD 99.968%
CSL Limited 12.18 Billion USD 100.0%
Cellectis S.A. 92.77 Million USD 99.978%